Insomnia Disorder: Epidemiology, Causes, and Pharmacotherapy

The field of sleep pharmacology is dynamic in nature and rapid advances are occurring in the field. For example, screening for new drug candidates, development of new drugs, identification of molecular targets, and works related to its efficacy and safety profiles. Furthermore, this leads to the development of evidence-based therapeutic guidelines. Insomnia Disorder: Epidemiology, Causes, and Pharmacotherapy consolidates the latest developments into one volume. It provides the latest, up-to-date knowledge regarding sleep and sleep therapeutics for sleep physicians, sleep researchers, psychiatrists, and any medical professional interested in the interdisciplinary areas of sleep therapeutics. Chapters include topics such as neurobiology, neurotransmitters, regulation of sleep and wakefulness, and overview of all current pharmacotherapies for insomnia. Consolidates new developments in the field of sleep pharmacotherapy Provides an authoritative reference for sleep physicians and researchers Discusses neurobiology, neurotransmitters, and regulation of sleep and wakefulness Overview on all current pharmacotherapies for insomnia INDICE: 1. Neurobiology of sleep and waking2. Neurotransmitters and sleep3. Regulation of sleep and wakefulness (two-process model of sleep and three-process model of alertness)3. Chronobiotics and chronohypnotics4. Normal sleep in children adolescents, adults, and older adults5. Insomnia: Overview and classification6. Insomnia characteristics in children, adolescents, adults, and older adults7. Mechanism of action of presently available hypnotic drugs8. Pharmacokinetics of presently available hypnotic drugs9. Non-pharmacological treatment of an insomnia disorder10. Benzodiazepine hypnotics11. Zeta drugs?: Zopiclone, Eszopiclone, Zolpidem, and Zaleplon12. Melatonin and melatonin receptor agonists (Ramelteon, Tasimelteon)13. Histamine H1 receptor antagonists (with special emphasis on low-dose Doxepin)14. Orexin receptor antagonists (Suvorexant, Lemborexant)15. Insomnia and CAM therapies: an evidence-based approach

• ISBN: 978-0-12-823412-9
• Editorial: Academic Press
• Encuadernacion: Rústica
• Páginas: 300
• Fecha Publicación: 01/03/2023
• Nº Volúmenes: 1
• Idioma: Inglés